Intelligence · Patents
Patents expiring in 2027
Annual patent cliff calendar for 2027 — US pharmaceutical patents by expiration date.
- Patents
- 578
Quick answer
578 indexed pharmaceutical patents have expiration dates in 2027. Browse by soonest expiry with links to assignee companies and related drugs.
-
US 7183268
2-amino-9-[(2-hydroxymethyl) cyclopropylidenemethyl] purine antiviral agents
granted -
US 7183267
β-lactamase inhibitors and methods of use thereof
granted -
US 7183065
Diagnosis, prevention and treatment of ulcerative colitis, and clinical subtypes thereof, using microbial UC pANCA antigens
granted -
US 7183255
Method for stabilizing blood pressure in hemodialysis subjects
granted -
US 7183307
Pyrazole-derived kinase inhibitors and uses thereof
granted -
US 7183095
Cell culture system for synthesis of infectious hepatitis C virus
granted -
US 7186698
Spatial and temporal control of gene expression using a heat shock protein promoter in combination with local heat
granted -
US 7186542
Method of extracting virus from cell culture
granted -
US 7186115
Advanced thermoplastics for orthodontics
granted -
US 7186737
Inhibitors of p38
granted -
US 7186413
Hydrogels and water soluble polymeric carriers for drug delivery
granted -
US 7189704
6-11 bicyclic ketolide derivatives
granted -
US 7189828
Glycosulfopeptide inhibitors of leukocyte rolling and methods of use thereof
granted -
US 7189812
Human gene critical to fertility
granted -
US 7189861
Processes for preparing amorphous atorvastatin hemi-calcium
granted -
US 7189706
C2,5′-disubstituted and N6,C2,5′-trisubstituted adenosine derivatives and pharmaceutical compositions containing them
granted -
US 7189741
Indolylpiperidine derivatives as antihistaminic and antiallergic agents
granted -
US 7189749
Substituted phenoxyacetic acids
granted -
US 7189744
Crystals of benzimidazole compounds
granted -
US 7189393
Recombinant anti-tumor RNAse
granted -
US 7189513
Human papilloma virus immunoreactive peptides
granted -
US 7189396
Delivery system using mAb 3E10 and mutants and/or functional fragments thereof
granted -
US 7189865
Thiomolybdate analogues and uses thereof
granted -
US 7189385
Tooth whitening compositions
granted -
US 7193075
Sequences upstream of the CARP gene, vectors containing them and uses thereof
granted -
US 7192546
Methods of forming shaped articles from suspensions
granted -
US 7192934
Vaccines for blocking transmission of Plasmodium vivax
granted -
US 7193053
Hypoxia-inducible factor 1alpha variants and methods of use
granted -
US 7192982
Modulators of peroxisome proliferator activated receptors
granted -
US 7193072
Compositions to identify swine genetically resistant to F18 E. coli associated diseases
granted -
US 7193034
Synthetic peptides, conjugation reagents and methods
granted -
US 7193033
Peptide having appetite stimulating activity
granted -
US 7192940
Ether compounds
granted -
US 7192914
Prevention of atherosclerosis and undesired blood clotting by reducing von Willebrand factor
granted -
US 7192978
Pyrrolidinium derivatives
granted -
US 7192735
Phosphopantetheinyl transferases and uses thereof
granted -
US 7192705
Transductin-1 and applications to hereditary deafness
granted -
US 7192932
Use of immunomodulating agents
granted -
US 7192704
Methods for detection and treatment of neural cancers
granted -
US 7192588
Vaccine composition and method of using the same
granted -
US 7192593
Use of recombinant parainfluenza viruses (PIVs) as vectors to protect against infection and disease caused by PIV and other human pathogens
granted -
US 7192583
Methods for modulating bone mineralization
granted -
US 7195911
Mammalian cells that have increased proliferative capacity
granted -
US 7195768
Polyvalent immunogen
granted -
US 7196222
Sertraline hydrochloride form II and methods for the preparation thereof
granted -
US 7196184
Double-stranded RNA (DSRNA) and method of use for inhibiting expression of the AML-1/MTG8 fusion gene
granted -
US 7196098
Quinuclidine derivatives and medicinal compositions containing the same
granted -
US 7196074
Methods of making, using and pharmaceutical formulations comprising 7α, 11β-dimethyl-17β-hydroxyestra-4, 14-dien-3-one and 17 esters thereof
granted
Frequently asked questions
How many pharma patents expire in 2027?
578 published patents in our USPTO index have expiration dates falling in calendar year 2027.